Ken-Ichiro Seino

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Infectious Diseases

Hematopoietic Stem Cell

Top Venues

Inflammation and regeneration

Cancer immunology, immunotherapy : CII

International immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Nabeel Kajihara, Yunqi Ge, Ken-Ichiro Seino
Blocking of oestrogen signals improves anti-tumour effect regardless of oestrogen receptor alpha expression in cancer cells. British journal of cancer (2023)
Tomoki Murata, Ryo Otsuka, Airi Sasaki, Tomoki Kamatani, Haruka Wada, Hisashi Yamakawa, Yoshinori Hasegawa, Ken-Ichiro Seino
Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells. International immunology (2023)
Haruka Wada, Ryo Otsuka, Wilfred T V Germeraad, Tomoki Murata, Toru Kondo, Ken-Ichiro Seino
Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition. Journal for immunotherapy of cancer 11 (11) (2023)
Nanumi Han, Haruka Wada, Takuto Kobayashi, Ryo Otsuka, Ken-Ichiro Seino
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin. Oncoimmunology 12 (1) (2023)
Ken-Ichiro Seino
Studies on immune regulation for allogeneic iPSC-based transplantation. Inflammation and regeneration 42 (1) (2022)
Ken-Ichiro Seino
Studies on immune regulation for allogeneic iPSC-based transplantation. Inflammation and regeneration 42 (1) (2022)
Tomoki Kamatani, Ryo Otsuka, Tomoki Murata, Haruka Wada, Takeshi Takahashi, Akihiro Mori, Soichiro Murata, Hideki Taniguchi, Ken-Ichiro Seino
Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model. Inflammation and regeneration 42 (1) (2022)
Ken-Ichiro Seino
Studies on immune regulation for allogeneic iPSC-based transplantation. Inflammation and regeneration 42 (1) (2022)
Nabeel Kajihara, Takuto Kobayashi, Ryo Otsuka, Junko Nio-Kobayashi, Tomohiro Oshino, Masato Takahashi, Seiichi Imanishi, Ari Hashimoto, Haruka Wada, Ken-Ichiro Seino
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer. Cancer immunology, immunotherapy : CII (2022)
Takayoshi Nakamura, Nabeel Kajihara, Naoki Hama, Takuto Kobayashi, Ryo Otsuka, Nanumi Han, Haruka Wada, Yoshinori Hasegawa, Nao Suzuki, Ken-Ichiro Seino
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor. Journal of gynecologic oncology (2022)
Ryo Otsuka, Ken-Ichiro Seino
Macrophage activation syndrome and COVID-19. Inflammation and regeneration 40 (2020)
Nanumi Han, Delnur Anwar, Naoki Hama, Takuto Kobayashi, Hidefumi Suzuki, Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, Ken-Ichiro Seino
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells. Inflammation and regeneration 40 (2020)
Nabeel Kajihara, Fumihito Kitagawa, Takuto Kobayashi, Haruka Wada, Ryo Otsuka, Ken-Ichiro Seino
Interleukin-34 contributes to poor prognosis in triple-negative breast cancer. Breast cancer (Tokyo, Japan) 27 (6) (2020)
Ryo Otsuka, Haruka Wada, Tomoki Murata, Ken-Ichiro Seino
Immune reaction and regulation in transplantation based on pluripotent stem cell technology. Inflammation and regeneration 40 (2020)